Pharmacogenetics in the management of breast cancer -- prospects for individualised treatment.
Affiliation
Department of Medical Oncology, Christie Hospital NHS Trust, M20 2BX, Manchester, UK.Issue Date
2006
Metadata
Show full item recordAbstract
Increased understanding of how variants in genes encoding metabolising enzymes, transporters and receptors affect drug efficacy and toxicity, in parallel with advances in genotyping technology means that clinical pharmacogenetics is drawing tantalisingly close to reality. This review considers some of the pharmacogenetic variants that have been described that are relevant to the management of women with breast cancer and how these may soon translate into clinical practice.Citation
Pharmacogenetics in the management of breast cancer -- prospects for individualised treatment. 2006, 5 (2):151-7 Fam. CancerJournal
Familial CancerDOI
10.1007/s10689-005-3241-5PubMed ID
16736284Type
ArticleLanguage
enISSN
1389-9600ae974a485f413a2113503eed53cd6c53
10.1007/s10689-005-3241-5
Scopus Count
Collections
Related articles
- Pharmacogenomics of tamoxifen and aromatase inhibitors.
- Authors: Ingle JN
- Issue date: 2008 Feb 1
- Pharmacogenetics in breast cancer therapy.
- Authors: Tan SH, Lee SC, Goh BC, Wong J
- Issue date: 2008 Dec 15
- Pharmacogenetics and pharmacogenomics of endocrine agents for breast cancer.
- Authors: Ingle JN
- Issue date: 2008
- Pharmacogenetics and oncology treatment for breast cancer.
- Authors: Marsh S, McLeod HL
- Issue date: 2007 Feb
- A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations.
- Authors: Pruthi S, Boughey JC, Brandt KR, Degnim AC, Dy GK, Goetz MP, Perez EA, Reynolds CA, Schomberg PJ, Ingle JN
- Issue date: 2007 Sep